Top

Environmental Health and Preventive Medicine

Published in:

Open Access 01-12-2021 | Tuberculosis | Research article

Survival of HIV/AIDS patients treated under ART follow-up at the University hospital, northwest Ethiopia

Authors: Zinabu Teka, Kasim Mohammed, Gashu Workneh, Zemichael Gizaw

Published in: Environmental Health and Preventive Medicine | Issue 1/2021

Abstract

Introduction

The survival of HIV/AIDS patients on antiretroviral therapy (ART) is determined by a number of factors, including economic, demographic, behavioral, and institutional factors. Understanding the survival time and its trend is crucial to developing policies that will result in changes. The aim of this study was to compare the survival estimates of different subgroups and look into the predictors of HIV/AIDS patient survival.

Methods

A retrospective cohort study of HIV/AIDS patients receiving ART at the University of Gondar teaching hospital was carried out. To compare the survival of various groups, a Kaplan-Meier survival analysis was performed. The Cox proportional hazards model was used to identify factors influencing HIV/AIDS patient survival rates.

Results

In the current study, 5.91% of the 354 HIV/AIDS patients under ART follow-up were uncensored or died. Age (HR = 1.051) and lack of formal education (HR = 5.032) were associated with lower survival rate, whereas family size of one to two (HR = 0.167), three to four (HR = 0.120), no alcoholic consumption (HR = 0.294), no smoking and chat use (HR = 0.101), baseline weight (HR = 0.920), current weight (HR = 0.928), baseline CD4 cell count (HR = 0.990), baseline hemoglobin (HR = 0.800), and no TB diseases were associated with longer survival rate.

Conclusions

Fewer deaths were reported in a study area due to high patient adherence, compared to previous similar studies. Age, educational status, family size, alcohol consumption, tobacco and chat usage, baseline and current weight, baseline CD4 cell count, baseline hemoglobin, and tuberculosis (TB) diseases were all significant predictors of survival of HIV/AIDS patients.

UNAIDS, “Global report: UNAIDS report on the global AIDS epidemic 2013, ”http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. (2013).

OARAC. Guidelines for the use of antiretroviral agents in HIV-1 Infected Adults and Adolescents, 2008.Available at http://aidsinfo.nih.gov/guidelines.

Jerene D. HIV antiretroviral therapy in Ethiopia: Overcoming implementation challenges. Doctoral thesis. University of Bergen, Norway. 2007. Available at https://bora.uib.no/bora-xmlui/handle/1956/2132?locale-attribute=en. Accessed 24 Feb 2015.

Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W. Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects. PLoS Med. 2009;6(4):e1000056. https://doi.org/10.1371/journal.pmed.1000056.CrossRefPubMedPubMedCentral

Isingo R, Zaba B, Marston M, Ndege M, Mngara J, Mwita W, Wringe A, Beckles D, Changalucha J, Urassa M: Survival after HIV infection in the pre-antiretroviral therapy era in a rural Tanzanian cohort. In.: LWW; 2007.

Assefa T, Wencheko E. Survival analysis of patients under chronic HIV-care and antiretroviral treatment at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop J Health Dev. 2012;26(1):22–9.

Cochran WG: Sampling techniques-3. 1977.

Goshu AT, Dessie ZG. Modelling progression of HIV/AIDS disease stages using semi-Markov processes. J Data Sci. 2013;11(2):269–80.CrossRef

Ayalew J, Moges H, Worku A. Identifying factors related to the survival of AIDS patients under the follow-up of antiretroviral therapy (ART): the case of South Wollo. Int J Data Envelopment Anal Oper Res. 2014;1(2):21–7.

10.

Tancredi MV, Waldman EA. Survival of AIDS patients in Sao Paulo-Brazil in the pre-and post-HAART eras: a cohort study. BMC Infect Dis. 2014;14(1):599. https://doi.org/10.1186/s12879-014-0599-8.CrossRefPubMedPubMedCentral

11.

Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6. https://doi.org/10.1056/NEJM199509213331202.CrossRefPubMed

12.

Vella S, Giuliano M, Floridia M, Chiesi A, Tomino C, Seeber A, et al. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. Aids. 1995;9(1):51–6. https://doi.org/10.1097/00002030-199501000-00007.CrossRefPubMed

13.

Damtew B, Mengistie B, Alemayehu T. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan Afr Med J. 2015;22(138):1–8.

14.

Jones CY, Hogan JW, Snyder B, Klein RS, Rompalo A, Schuman P, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis. 2003;37(Suppl 2):S69–80. https://doi.org/10.1086/375889.CrossRefPubMed

15.

Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr. 2001;26(3):291–7.CrossRef

16.

Blashill AJ, Mayer KH, Crane HM, Grasso C, Safren SA. Body mass index, immune status, and virological control in HIV-infected men who have sex with men. J Int Assoc Providers AIDS Care (JIAPAC). 2013;12(5):319–24. https://doi.org/10.1177/2325957413488182.CrossRef

17.

Shor-Posner G, Campa A, Zhang G, Persaud N, Miguez-Burbano M-J, Quesada J, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr. 2000;23(1):81–8.CrossRef

18.

Sharma A, Hoover DR, Shi Q, Gustafson D, Plankey MW, Hershow RC, et al. Relationship between body mass index and mortality in HIV-infected HAART users in the women's interagency HIV study. PloS One. 2015;10(12):e0143740. https://doi.org/10.1371/journal.pone.0143740.CrossRefPubMedPubMedCentral

19.

Crum-Cianflone NF, Roediger M, Eberly LE, Vyas K, Landrum ML, Ganesan A, et al. Obesity among HIV-infected persons: impact of weight on CD4 cell count. AIDS. 2010;24(7):1069.CrossRef

20.

Womack J, Tien PC, Feldman J, Shin JH, Fennie K, Anastos K, et al. Obesity and immune cell counts in women. Metabolism. 2007;56(7):998–1004. https://doi.org/10.1016/j.metabol.2007.03.008.CrossRefPubMedPubMedCentral

21.

Quach LA, Wanke CA, Schmid CH, Gorbach SL, Mwamburi DM, Mayer KH, et al. Drug use and other risk factors related to lower body mass index among HIV-infected individuals. Drug Alcohol Dependence. 2008;95(1-2):30–6. https://doi.org/10.1016/j.drugalcdep.2007.12.004.CrossRefPubMed

22.

Palenicek JP, Graham N, He YD, Hoover DA, Oishi JS, Kingsley L, et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(3):366–73.CrossRef

23.

Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(2):230–6.CrossRef

24.

Palella FJ, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138(8):620–6. https://doi.org/10.7326/0003-4819-138-8-200304150-00007.CrossRefPubMed

25.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, et al. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009;151(3):157–66. https://doi.org/10.7326/0003-4819-151-3-200908040-00138.CrossRefPubMedPubMedCentral

26.

Maman D, Pujades-Rodriguez M, Nicholas S, McGuire M, Szumilin E, Ecochard R, et al. Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl. Aids. 2012;26(11):1393–8. https://doi.org/10.1097/QAD.0b013e328352d054.CrossRefPubMed

27.

Wang C, Masho S, Nixon D, Nelson KE. When to start HAART for the treatment of HIV infection. The Lancet infectious diseases. 2007;7(1):5–6. https://doi.org/10.1016/S1473-3099(06)70664-8.CrossRefPubMed

28.

Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26. https://doi.org/10.1056/NEJMoa0807252.CrossRefPubMedPubMedCentral

Title: Survival of HIV/AIDS patients treated under ART follow-up at the University hospital, northwest Ethiopia
Authors: Zinabu Teka
Kasim Mohammed
Gashu Workneh
Zemichael Gizaw
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Tuberculosis
Tuberculosis
Human Immunodeficiency Virus
Acquired Immune Deficiency Syndrome
Published in: Environmental Health and Preventive Medicine / Issue 1/2021
Print ISSN: 1342-078X
Electronic ISSN: 1347-4715
DOI: https://doi.org/10.1186/s12199-021-00976-8

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Survival of HIV/AIDS patients treated under ART follow-up at the University hospital, northwest Ethiopia

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

The willingness for dietary and behavioral changes in frontline epidemic prevention workers after experiencing the outbreak of COVID-19 in China: a cross-sectional study

Effects of exposure to low-dose ionizing radiation on changing platelets: a prospective cohort study

Relationship between maternal employment status and children’s food intake in Japan

Education and household income and carotid intima-media thickness in Japan: baseline data from the Aidai Cohort Study in Yawatahama, Uchiko, Seiyo, and Ainan

Associations of education and income with hazardous drinking among postpartum women in Japan: results from the TMM BirThree Cohort Study

Associations of negative life events and coping styles with sleep quality among Chinese adolescents: a cross-sectional study